Simplex Trading’s Cymabay Therapeutics CBAY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-55,629
| Closed | -$991K | – | 10147 |
|
|
2023
Q3 | $829K | Buy |
+55,629
| New | +$738K | ﹤0.01% | 2869 |
|
|
2022
Q2 | – | Sell |
-5,574
| Closed | -$13.3K | – | 11423 |
|
|
2022
Q1 | $17K | Buy |
+5,574
| New | +$17.5K | ﹤0.01% | 8431 |
|
|
2021
Q4 | – | Sell |
-11,198
| Closed | -$42.5K | – | 11707 |
|
|
2021
Q3 | $49K | Hold |
11,198
| – | – | ﹤0.01% | 7532 |
|
|
2021
Q2 | $48K | Buy |
11,198
+6,945
| +163% | +$30.8K | ﹤0.01% | 7689 |
|
|
2021
Q1 | $19K | Buy |
4,253
+855
| +25% | +$4.6K | ﹤0.01% | 7507 |
|
|
2020
Q4 | $0 | Sell |
3,398
-3,780
| -53% | -$28.6K | ﹤0.01% | 9272 |
|
|
2020
Q3 | $0 | Sell |
7,178
-22,864
| -76% | -$122K | ﹤0.01% | 8724 |
|
|
2020
Q2 | $0 | Buy |
+30,042
| New | +$86.7K | ﹤0.01% | 8570 |
|
|
2020
Q1 | – | Sell |
-6,829
| Closed | -$11.5K | – | 8462 |
|
|
2019
Q4 | $13K | Buy |
6,829
+5,678
| +493% | +$21.3K | ﹤0.01% | 6260 |
|
|
2019
Q3 | $5K | Sell |
1,151
-50,494
| -98% | -$306K | ﹤0.01% | 6639 |
|
|
2019
Q2 | $369K | Buy |
51,645
+46,496
| +903% | +$526K | ﹤0.01% | 2877 |
|
|
2019
Q1 | $68K | Sell |
5,149
-348
| -6% | -$3.7K | ﹤0.01% | 4737 |
|
|
2018
Q4 | $43K | Buy |
5,497
+1,593
| +41% | +$15.2K | ﹤0.01% | 4666 |
|
|
2018
Q3 | $43K | Buy |
+3,904
| New | +$48.5K | ﹤0.01% | 5319 |
|
Other funds holding CBAY
Simplex Trading's CBAY Position: Q4 2023 in Review
Simplex Trading sold out of Cymabay Therapeutics (CBAY) in Q4 2023, closing a stake of 55,629 shares — an estimated $991K sold.
Simplex Trading first reported a position in CBAY in Q3 2018 and held it in 14 quarters. The position peaked at $829K in Q3 2023. 200 funds tracked by Wall St. Rank hold CBAY as of Q4 2023.
- Simplex Trading reported no remaining Cymabay Therapeutics position as of Q4 2023 after selling out during the quarter.
- Simplex Trading sold 55,629 Cymabay Therapeutics shares in Q4 2023, an estimated $991K.
- Simplex Trading first reported a position in Cymabay Therapeutics in Q3 2018 and held it in 14 quarters.
- Simplex Trading's Cymabay Therapeutics position peaked at $829K in Q3 2023.
- 200 funds tracked by Wall St. Rank held Cymabay Therapeutics as of Q4 2023.
Based on Simplex Trading's 13F filing for Q4 2023, filed 2 Feb 2024.